To include your compound in the COVID-19 Resource Center, submit it here.

3-V reports Phase I data for NASH candidate

3-V Biosciences Inc. (Menlo Park, Calif.) reported data from a Phase I trial in 20 healthy volunteers

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE